v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common stock
Paid-in capital
Accumulated deficit
Accumulated other comprehensive  loss
Beginning Balance (in shares) at Dec. 31, 2024   22,156,000      
Balance at beginning of year at Dec. 31, 2024 $ 229,923 $ 222 $ 280,566 $ (32,550) $ (18,315)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net (loss) income (4,201)     (4,201)  
Other comprehensive income (loss), net of taxes 292       292
Net issuance of restricted shares granted to employees and directors (in shares)   338,000      
Net issuance of restricted shares granted to employees and directors 0 $ 3 (3)    
Stock compensation expense 1,063   1,063    
Shares effectively repurchased for required employee withholding taxes (in shares)   (80,000)      
Shares effectively repurchased for required employee withholding taxes (416) $ (1) (415)    
Dividends [1] (985)     (985)  
Ending Balance (in shares) at Mar. 31, 2025   22,414,000      
Balance at end of year at Mar. 31, 2025 225,676 $ 224 281,211 (37,736) (18,023)
Beginning Balance (in shares) at Dec. 31, 2024   22,156,000      
Balance at beginning of year at Dec. 31, 2024 229,923 $ 222 280,566 (32,550) (18,315)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net (loss) income (45,089)        
Other comprehensive income (loss), net of taxes 95        
Ending Balance (in shares) at Sep. 30, 2025   22,657,000      
Balance at end of year at Sep. 30, 2025 184,645 $ 227 283,248 (80,610) (18,220)
Beginning Balance (in shares) at Mar. 31, 2025   22,414,000      
Balance at beginning of year at Mar. 31, 2025 225,676 $ 224 281,211 (37,736) (18,023)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net (loss) income (39,699)     (39,699)  
Other comprehensive income (loss), net of taxes (262)       (262)
Net issuance of restricted shares granted to employees and directors (in shares)   243,000      
Net issuance of restricted shares granted to employees and directors 0 $ 3 (3)    
Stock compensation expense 1,044   1,044    
Dividends [1] (991)     (991)  
Ending Balance (in shares) at Jun. 30, 2025   22,657,000      
Balance at end of year at Jun. 30, 2025 185,768 $ 227 282,252 (78,426) (18,285)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net (loss) income (1,189)     (1,189)  
Other comprehensive income (loss), net of taxes 65       65
Stock compensation expense 996   996    
Dividends [1] (995)     (995)  
Ending Balance (in shares) at Sep. 30, 2025   22,657,000      
Balance at end of year at Sep. 30, 2025 184,645 $ 227 283,248 (80,610) (18,220)
Beginning Balance (in shares) at Dec. 31, 2025   22,654,000      
Balance at beginning of year at Dec. 31, 2025 202,277 $ 227 283,449 (63,354) (18,045)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net (loss) income (4,772)     (4,772)  
Other comprehensive income (loss), net of taxes 139       139
Net issuance of restricted shares granted to employees and directors (in shares)   259,000      
Net issuance of restricted shares granted to employees and directors 0 $ 3 (3)    
Stock compensation expense 1,041   1,041    
Shares effectively repurchased for required employee withholding taxes (in shares)   (58,000)      
Shares effectively repurchased for required employee withholding taxes (183) $ (1) (182)    
Dividends [1] (1,006)     (1,006)  
Ending Balance (in shares) at Mar. 31, 2026   22,855,000      
Balance at end of year at Mar. 31, 2026 197,496 $ 229 284,305 (69,132) (17,906)
Beginning Balance (in shares) at Dec. 31, 2025   22,654,000      
Balance at beginning of year at Dec. 31, 2025 202,277 $ 227 283,449 (63,354) (18,045)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net (loss) income 10,642        
Other comprehensive income (loss), net of taxes $ 297        
Net exercise of stock options (in shares) 49,375        
Ending Balance (in shares) at Sep. 30, 2026   22,984,000      
Balance at end of year at Sep. 30, 2026 $ 213,218 $ 230 286,472 (55,736) (17,748)
Beginning Balance (in shares) at Mar. 31, 2026   22,855,000      
Balance at beginning of year at Mar. 31, 2026 197,496 $ 229 284,305 (69,132) (17,906)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net (loss) income 19,609     19,609  
Other comprehensive income (loss), net of taxes 115       115
Net issuance of restricted shares granted to employees and directors (in shares)   85,000      
Net issuance of restricted shares granted to employees and directors 0 $ 1 (1)    
Stock compensation expense 973   973    
Net exercise of stock options (in shares)   49,000      
Net exercise of stock options 294   294    
Dividends [1] (1,010)     (1,010)  
Ending Balance (in shares) at Jun. 30, 2026   22,989,000      
Balance at end of year at Jun. 30, 2026 217,477 $ 230 285,571 (50,533) (17,791)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net (loss) income (4,195)     (4,195)  
Other comprehensive income (loss), net of taxes 43       43
Net issuance of restricted shares granted to employees (in shares)   (5,000)      
Stock compensation expense 901   901    
Dividends [1] (1,008)     (1,008)  
Ending Balance (in shares) at Sep. 30, 2026   22,984,000      
Balance at end of year at Sep. 30, 2026 $ 213,218 $ 230 $ 286,472 $ (55,736) $ (17,748)
[1] Cash dividends declared per share of common stock were $0.1275 and $0.1275 in the nine months ended September 30, 2026 and 2025, respectively.